Join to View Full Profile
600 Highland AveMadison, WI 53792
Phone+1 608-265-1700
Fax+1 608-262-1982
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 3 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. George Wilding, MD is an oncologist in Madison, Wisconsin. He is currently licensed to practice medicine in Wisconsin and Texas. He is a "Vice Provost of Clinical and Interdisciplinary Research at The University.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1983 - 1986
UMass Chan Medical SchoolResidency, Internal Medicine, 1980 - 1983- University of Massachusetts Medical SchoolClass of 1980
Certifications & Licensure
WI State Medical License 1988 - 2027
TX State Medical License 2018 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 1 Certification PRISM, IOD Incorporated, 2013-2014
- CMS Meaningful Use Stage Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014
- CMS Meaningful Use Stage Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014
Publications & Presentations
PubMed
- 2 citationsOverall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma.Robert J Motzer, Thomas E Hutson, Piotr Tomczak, M Dror Michaelson, Ronald M Bukowski
Journal of Clinical Oncology. 2023-04-10 - 18 citationsPredicting Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy Using a Deep Convolutional Neural Network-Based Artificial Intelligence Tool.Savitri Krishnamurthy, Parag Jain, Debu Tripathy, Roland Basset, Ramandeep Randhawa
JCO Clinical Cancer Informatics. 2023-03-01 - 21 citationsA Novel Artificial Intelligence-Powered Method for Prediction of Early Recurrence of Prostate Cancer After Prostatectomy and Cancer Drivers.Wei Huang, Ramandeep Randhawa, Parag Jain, Samuel Hubbard, Jens Eickhoff
JCO Clinical Cancer Informatics. 2022-02-01
Press Mentions
How Unexpected Results Can Lead Cancer Research and Treatment in New DirectionsJanuary 7th, 2019
Intermittent Androgen Deprivation Not Equivalent to Continuous Treatment for Prostate Cancer, May Compromise SurvivalApril 5th, 2013
